The Hydration Pharmaceuticals Company Limited (ASX:HPC)
Australia
· Delayed Price · Currency is AUD 0.0110
0.00 (0.00%)
May 14, 2025, 3:23 PM AEST
ASX:HPC Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Revenue | 3.2 | 4.3 | 9.1 | 6.13 | 3.76 | Upgrade
|
| Revenue Growth (YoY) | -25.48% | -52.74% | 48.52% | 63.10% | 26.79% | Upgrade
|
| Cost of Revenue | 1.58 | 2.4 | 4.4 | 3.34 | 2.42 | Upgrade
|
| Gross Profit | 1.62 | 1.9 | 4.7 | 2.79 | 1.34 | Upgrade
|
| Selling, General & Admin | 5.82 | 8.77 | 15.4 | 9.62 | 4.61 | Upgrade
|
| Operating Expenses | 5.82 | 8.77 | 15.4 | 9.62 | 4.64 | Upgrade
|
| Operating Income | -4.2 | -6.87 | -10.7 | -6.83 | -3.3 | Upgrade
|
| Interest Expense | -1.76 | -0.64 | -0.09 | -2.54 | -0.01 | Upgrade
|
| Interest & Investment Income | - | - | - | - | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.4 | -0.01 | 0.12 | 1.41 | -0.25 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.11 | 0.29 | 0.07 | 0 | 0.07 | Upgrade
|
| EBT Excluding Unusual Items | -5.67 | -7.23 | -10.61 | -7.97 | -3.49 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 2.75 | Upgrade
|
| Other Unusual Items | - | - | - | -0.99 | - | Upgrade
|
| Pretax Income | -5.67 | -7.23 | -10.61 | -8.95 | -0.74 | Upgrade
|
| Earnings From Continuing Operations | -5.67 | -7.23 | -10.61 | -8.95 | -0.74 | Upgrade
|
| Earnings From Discontinued Operations | 8.34 | -0.87 | - | - | - | Upgrade
|
| Net Income | 2.67 | -8.1 | -10.61 | -8.95 | -0.74 | Upgrade
|
| Net Income to Common | 2.67 | -8.1 | -10.61 | -8.95 | -0.74 | Upgrade
|
| Shares Outstanding (Basic) | 291 | 195 | 163 | 76 | 65 | Upgrade
|
| Shares Outstanding (Diluted) | 373 | 195 | 163 | 76 | 65 | Upgrade
|
| Shares Change (YoY) | 91.04% | 19.95% | 115.37% | 16.35% | 14.36% | Upgrade
|
| EPS (Basic) | 0.01 | -0.04 | -0.07 | -0.12 | -0.01 | Upgrade
|
| EPS (Diluted) | 0.00 | -0.04 | -0.07 | -0.12 | -0.01 | Upgrade
|
| Free Cash Flow | -3.88 | -5.73 | -9.75 | -8.08 | -3.88 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.03 | -0.06 | -0.11 | -0.06 | Upgrade
|
| Gross Margin | 50.58% | 44.18% | 51.61% | 45.53% | 35.55% | Upgrade
|
| Operating Margin | -130.95% | -159.62% | -117.60% | -111.52% | -87.84% | Upgrade
|
| Profit Margin | 83.23% | -188.39% | -116.56% | -146.10% | -19.80% | Upgrade
|
| Free Cash Flow Margin | -121.03% | -133.22% | -107.16% | -131.84% | -103.29% | Upgrade
|
| EBITDA | - | - | -10.7 | -6.83 | -3.28 | Upgrade
|
| EBITDA Margin | - | - | -117.57% | -111.47% | -87.21% | Upgrade
|
| D&A For EBITDA | - | - | 0 | 0 | 0.02 | Upgrade
|
| EBIT | -4.2 | -6.87 | -10.7 | -6.83 | -3.3 | Upgrade
|
| EBIT Margin | -130.95% | -159.62% | -117.60% | -111.52% | -87.84% | Upgrade
|
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.